BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Amazon Yanks Pharma License App in Maine

  Amazon didn’t immediately respond to a request for comment.

  December 6, 2017

   · 

  1 min read
• 

  Titan Medical Seals Upsized $18M Funding Round

  The funding round brought in nearly $4 million more than it was originally expecting.

  December 6, 2017

   · 

  1 min read
• 

  Business

  What You Need to Know About DMD Therapeutics

  DMD Therapeutics is based in Seattle, although at present it is a virtual company, and, as its name suggests, is focused on developing therapeutics for DMD.

  December 6, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  What You Need to Know About Fortis Therapeutics

  Fortis Therapeutics is focused on immuno-oncology, specifically on developing an ADC for multiple myeloma and late-stage prostate cancer, including both the adenocarcinoma and neuroendocrine types.

  December 6, 2017

   · 

  3 min read

   · 

  Mark Terry
• Policy

  FDA Slaps Warning on Bay Area’s Hand Biomechanics Lab for Failing to Disclose Serious Injury

  The firm failed to submit a report to the agency of a serious injury that may have been caused by one of the company’s medical devices.

  December 6, 2017

   · 

  1 min read
• 

  Policy

  Abbott Maintains Nanostim Leadless Pacemaker Halt on Docking Button Issue

  The 3.6mm docking button is designed to allow the Nanostim device to be retrieved after implantation.

  December 6, 2017

   · 

  1 min read
• Policy

  Medtronic Partner Mazor Robotics’ CEO Under Investigation for Insider Trading

  The investigation dates back to a probe launched in May by Israel’s version of the U.S. SEC though the subject matter of the investigation was not initially revealed.

  December 6, 2017

   · 

  1 min read
• 

  Policy

  SoCal’s Avanir Scrutinized for Nudexta Prescriber Support Program

  Avanir is under fire after CNN filed a report showing how the company paid 500 prescribers about $14M over three years for prescribers to tout the benefits of its leading CNS drug Nuedexta.

  December 6, 2017

   · 

  2 min read

   · 

  Alex Keown
• Business

  Abionic Announces Appointment of Leading Diagnostics Industry Experts to Board of Directors

  Gerd Grenner, PhD, has more than 35 years’ experience in R&D management positions in medical diagnostics companies.

  December 6, 2017

   · 

  3 min read
• Business

  General Partner AmorChem II Ventures Announces Establishment and Launch of New Fund, AmorChem II Fund L.P.

  AmorChem II is backed by the following limited partners: the Québec government, Fonds de solidarité FTQ, Merck and other qualified investors.

  December 6, 2017

   · 

  4 min read